11th International Conference on Thrombosis and Hemostasis Issues in Cancer



On the agenda:

  • Venous thromboembolism (VTE) in cancer in contemporary era
  • Contemporary breast cancer treatment-associated thrombosis
  • Machine learning for risk stratification of cancer-associated thrombosis (CAT)
  • VTE and risk stratification in hematological malignancies
  • P-Selectin as an emerging target for cancer therapy
  • Cancer genetic alterations and risk of VTE
  • The role of neutrophil extracellular traps in cancer-associated thrombosis
  • Role and regulation of TFPI and FV in tumor cells
  • Bi-directional cross talk between coagulation and cancers: Current assessment of pre-clinical evidence
  • PET scan for occult cancer among patients with unprovoked VTE: What do we know?
  • The relationship between platelets and cancer cells in the growing thrombus and in the development of cancer
  • Debate: Catheter-associated thrombosis in cancer patients: To prophylax or not to prophylax?
  • Venous and arterial thromboembolism in patients with cancer treated with targeted anti-cancer treatments
  • Drug-drug interactions: Implications for anticoagulation use in patients with cancer
  • Bleeding risk with direct oral anticoagulants in cancer patients
  • Cancer and COVID-19: Where are the data?
  • COVID-19-associated coagulopathy and thrombosis in cancer
  • Roundtable: Multidisciplinary approach in cardiovascular oncology: Building a CAT Clinic - Real-World Systems Approaches to Prevention and Treatment
  • Cardiotoxic effects of antitumor agents: Pathogenetic mechanisms
Possible contact: scientificsecretariat@icthic.com

Venue: Centro Congressi Giovanni XXIII


May 27-29, 2022


Bergamo, Italy